BRISTOL MYERS SQUIBB
- Country
- ๐ซ๐ทFrance
- Ownership
- -
- Established
- 1989-01-01
- Employees
- 30K
- Market Cap
- $97.5B
- Website
- https://www.bms.com/
Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML
- Conditions
- Interventions
- First Posted Date
- 2005-07-25
- Last Posted Date
- 2014-11-02
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 638
- Registration Number
- NCT00123487
- Locations
- ๐บ๐ธ
The University Of North Carolina At Chapel Hill, Chapel Hill, North Carolina, United States
๐บ๐ธWashington University School Of Medicine, Saint Louis, Missouri, United States
๐บ๐ธEmory University School Of Medicine, Atlanta, Georgia, United States
Remission and Joint Damage Progression in Early Rheumatoid Arthritis
- Conditions
- Interventions
- First Posted Date
- 2005-07-22
- Last Posted Date
- 2010-11-16
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 1052
- Registration Number
- NCT00122382
- Locations
- ๐ฌ๐ง
Local Institution, Newcastle, Northumberland, United Kingdom
๐บ๐ธLion Research, Norman, Oklahoma, United States
๐บ๐ธDiagnostic Rheumatology And Research, Indianapolis, Indiana, United States
Study of HIV Patients With Undetectable Viral Load and Abnormal Lipids Switching to Atazanavir/Ritonavir
- Conditions
- Interventions
- First Posted Date
- 2005-07-18
- Last Posted Date
- 2010-02-05
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 192
- Registration Number
- NCT00120393
- Locations
- ๐จ๐ฆ
Local Institution, Montreal, Quebec, Canada
Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone
- Conditions
- Interventions
- First Posted Date
- 2005-07-14
- Last Posted Date
- 2014-09-22
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 183
- Registration Number
- NCT00119678
- Locations
- ๐บ๐ธ
8737 Beverly Blvd., Los Angeles, California, United States
๐บ๐ธOffice Of Geoffrey S. Dolan, Md, Long Beach, California, United States
๐บ๐ธKentuckiana Center For Better Bone And Joint Health, Louisville, Kentucky, United States
DART I - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy
- Conditions
- First Posted Date
- 2005-06-30
- Last Posted Date
- 2011-04-22
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 65
- Registration Number
- NCT00116415
- Locations
- ๐บ๐ธ
Local Institution, Dallas, Texas, United States
Rollover Study for Zerit (Stavudine) ER Studies (-096, -099)
- Conditions
- First Posted Date
- 2005-06-29
- Last Posted Date
- 2011-04-25
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 900
- Registration Number
- NCT00116298
- Locations
- ๐น๐ญ
Local Institution, Nontaburi, Thailand
DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy
- Conditions
- First Posted Date
- 2005-06-28
- Last Posted Date
- 2011-04-26
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 70
- Registration Number
- NCT00116116
- Locations
- ๐บ๐ธ
Local Institution, Dallas, Texas, United States
Study of Belatacept in Subjects Who Are Undergoing a Renal Transplant
- Conditions
- Interventions
- First Posted Date
- 2005-06-20
- Last Posted Date
- 2017-07-07
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 595
- Registration Number
- NCT00114777
- Locations
- ๐บ๐ธ
Sharp Memorial Hospital, San Diego, California, United States
๐บ๐ธUniversity Of Alabama At Birmingham, Birmingham, Alabama, United States
๐บ๐ธNational Institute Of Transplantation, Los Angeles, California, United States
Safety and Efficacy of Veronateยฎ Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants
- Conditions
- First Posted Date
- 2005-06-07
- Last Posted Date
- 2012-08-02
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 2000
- Registration Number
- NCT00113191
MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery
- Conditions
- First Posted Date
- 2005-06-03
- Last Posted Date
- 2021-09-27
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 27
- Registration Number
- NCT00112580
- Locations
- ๐บ๐ธ
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office, Bethesda, Maryland, United States
๐บ๐ธNCI - Surgery Branch, Bethesda, Maryland, United States